Clinical Course, Immunogenicity, and Efficacy of BNT162b2 mRNA Vaccination Against SARS-CoV-2 Infection in Liver Transplant Recipients

BACKGROUND. Immunocompromised individuals have been excluded from landmark studies of messenger RNA vaccinations for severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2). In such patients, the response to vaccination may be blunted and may wane more quickly compared with immunocompetent...

Descripción completa

Detalles Bibliográficos
Autores principales: Tan, Eunice X., Lim, Wen Hui, Thong, Elizabeth, Chavatte, Jean-Marc, Zhang, Jinyan, Lim, Jonathan, Jin, Jocelyn Y., Lim, Daniel R.X., Kang, Jaclyn Y.T., Tang, Ansel Shao Pin, Chan, Kai En, Tan, Caitlyn, Tan, Shi Ni, Nah, Benjamin, Huang, Daniel Q., Wang, Lin-Fa, Tambyah, Paul A., Somani, Jyoti, Young, Barnaby, Muthiah, Mark D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Liver Transplantation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10513132/
https://www.ncbi.nlm.nih.gov/pubmed/37745946
http://dx.doi.org/10.1097/TXD.0000000000001537

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10513132/
https://www.ncbi.nlm.nih.gov/pubmed/37745946
http://dx.doi.org/10.1097/TXD.0000000000001537

Ejemplares similares